CIPHER PHARMACEUTICALS INC (CPH.CA) Stock Analyst Ratings
Canada - TSX:CPH - CA17253X1050 - Common Stock
14.815 CAD
-0.12 (-0.77%)
ChartMill assigns a Buy % Consensus number of 78% to CPH.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.26. This target is 23.24% above the current price.
CPH.CA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CPH.CA.
In the previous month the buy percentage consensus was at a similar level.
CPH.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-03-23 | Leede Jones Gab | Upgrade | Speculative Buy -> Buy |
CIPHER PHARMACEUTICALS INC / CPH.CA FAQ
What do analysts expect the price target to be for CIPHER PHARMACEUTICALS INC (CPH.CA)?
9 analysts have analysed CPH.CA and the average price target is 18.26 CAD. This implies a price increase of 23.24% is expected in the next year compared to the current price of 14.815.
What is the consensus rating for CIPHER PHARMACEUTICALS INC (CPH.CA) stock?
The consensus rating for CIPHER PHARMACEUTICALS INC (CPH.CA) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.